NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/14/2026
Back to search
Official data from USPTO
FENOPRON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/14/2026
Trademark type
Word
Nice classes
5
Filing date
08/14/2024
Registration date
07/14/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2026
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/30/2024
First use in commerce
07/07/2025
Drawing code
4
Owner type
16
Owner location
Atlanta, GA, US
Examiner
THOMPSON, HEATHER
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Galt Pharmaceuticals, LLC
Representatives
Chelsea G. Swanson
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesic preparations; Anti-inflammatory preparations; Pain relief medication; Pharmaceutical preparations for treating pain and inflammation
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/21/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/21/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/03/2026
IUAF
USE AMENDMENT FILED
02/11/2026
EISU
TEAS STATEMENT OF USE RECEIVED
02/11/2026
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
02/11/2026
NREV
NOTICE OF REVIVAL - E-MAILED
02/11/2026
PETG
PETITION TO REVIVE-GRANTED
02/11/2026
PROA
TEAS PETITION TO REVIVE RECEIVED
02/11/2026
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02/09/2026
ABN6
ABANDONMENT - NO USE STATEMENT FILED
02/09/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/20/2025
EX1G
SOU EXTENSION 1 GRANTED
06/19/2025
EXT1
SOU EXTENSION 1 FILED
06/19/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/19/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2024
PUBO
PUBLISHED FOR OPPOSITION
11/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/29/2024
DOCK
ASSIGNED TO EXAMINER
10/28/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2024
NWAP
NEW APPLICATION ENTERED
08/14/2024
Continuous trademark protection
Get notified about every new filing that threatens FENOPRON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.